🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers market the substance there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and chemists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could result in users injecting products of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and customer laws, risking fines, prosecution or prison.

Platform Reaction and Material Elimination

Based on the social media company, the service has taken down violative content and banned related hashtags and search suggestions. The organization said it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Research also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, populated with photos of slimming results, glowing reviews and detailed instructions for preparing or injecting at home.

After minutes of entering one group, a vendor posted contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Details and Costs

Inside these groups, posts display dark colored packages with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for Telegram stated it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has already encountered patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company investigational product not yet authorized … may expose users to potentially serious medical dangers”.